A Clinical Measure of DNA Methylation Predicts Outcome in De Novo AML
Year: 2015
Type: article
Study design: Observational Study
Source: Blood
Institutions: Brigham and Women's Hospital, University of Pennsylvania, Children's Hospital of Philadelphia, Abramson Cancer Center, University of Michigan, Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, Montefiore Medical Center, Montefiore Einstein Comprehensive Cancer Center, Mayo Clinic, Moffitt Cancer Center, Weill Cornell Medicine
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2554400449
